The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Safety and efficacy of tumor necrosis factor α blockade in systemic lupus erythematosus: An open‐label study
Abstract
Objective: To investigate the safety of therapeutic tumor necrosis factor α (TNFα) blockade in patients with systemic lupus erythematosus (SLE), in whom this proinflammatory cytokine is significantly increased and may be involved in the disease pathogenesis. Methods: In an open‐label study, 6 patients with moderately active SLE (4 with nephritis and 3 with arthritis refractory to other therapies) were given 4 300‐mg doses of infliximab, a chimeric anti‐TNFα antibody, in addition to immunosuppression with azathioprine or methotrexate. Results: The only significant adverse events observed were urinary tract infection in 3 patients, 1 of which was accompanied by Escherichia coli bacteremia, and a prolonged febrile episode of putatively viral origin in 1 of them. These patients had similar infectious conditions in the past. In none of the patients was it necessary to terminate the treatment prematurely. Levels of antibodies to double‐stranded DNA and cardiolipin increased in 4 patients each, but this was not associated with a decrease in serum complement levels, with vascular events, or with flares. In contrast, disease activity declined during therapy. All 3 patients with joint involvement experienced remission of arthritis, which relapsed 8–11 weeks after the last infliximab infusion. In the 4 patients with lupus nephritis, proteinuria decreased significantly within 1 week after initiation of therapy and was diminished by ≥60% within 8 weeks, remaining at low levels until the end of the observation period (at least several months). Conclusion: Infliximab did not lead to adverse events related to an increase in SLE activity, although autoantibodies to double‐stranded DNA and cardiolipin increased, as expected. This finding, coupled with the clinical improvement in the inflammatory manifestations of the disease, indicates that further study in larger controlled trials is warranted.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The 1982 revised criteria for the classification of systemic lupus erythematosus
Tan, E. M., Cohen, A. S., Fries, J. F., Masi, A. T., Mcshane, D. J., Rothfield, N. F., Schaller, J. G., Talal, N., & Winchester, R. J. (1982) · Arthritis & Rheumatism · doi:10.1002/art.1780251101 · Cited by 14,519
Dinarello, C. A. (2000) · Chest · doi:10.1378/chest.118.2.503 · Cited by 2,045
Signal transduction by tumor necrosis factor and its relatives
Baud, V., & Karin, M. (2001) · Trends in Cell Biology · doi:10.1016/s0962-8924(01)02064-5 · Cited by 1,655
Anti-TNFα Therapy of Rheumatoid Arthritis: What Have We Learned?
Feldmann, M., & Maini, R. N. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.163 · Cited by 1,257
Davidson, A., & Diamond, B. (2001) · New England Journal of Medicine · doi:10.1056/nejm200108023450506 · Cited by 1,042
Hahn, B. H. (1998) · New England Journal of Medicine · doi:10.1056/nejm199805073381906 · Cited by 682
O'Shea, J. J., Ma, A., & Lipsky, P. (2002) · Nature Reviews Immunology · doi:10.1038/nri702 · Cited by 675
Elliott, M. J., Maini, R. N., Feldmann, M., Long-Fox, A., Charles, P., Bijl, J. A., & Woody, J. N. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90632-7 · Cited by 640
Uncoupling of Immune Complex Formation and Kidney Damage in Autoimmune Glomerulonephritis
Clynes, R., Dumitru, C., & Ravetch, J. V. (1998) · Science · doi:10.1126/science.279.5353.1052 · Cited by 625
Tumour necrosis factor-α in murine autoimmune 'lupus' nephritis
Jacob, C. O., & McDevitt, H. O. (1988) · Nature · doi:10.1038/331356a0 · Cited by 596
An open study of B lymphocyte depletion in systemic lupus erythematosus
Leandro, M. J., Edwards, J. C., Cambridge, G., Ehrenstein, M. R., & Isenberg, D. A. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10541 · Cited by 576
Autoantibodies in the diagnosis of systemicrheumatic diseases
von Mühlen, C. A., & Tan, E. M. (1995) · Seminars in Arthritis and Rheumatism · doi:10.1016/s0049-0172(95)80004-2 · Cited by 546
Brandt, J., Haibel, H., Cornely, D., Golder, W., Gonzalez, J., Reddig, J., Thriene, W., Sieper, J., & Braun, J. (2000) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200006)43:6<1346::aid-anr18>3.0.co;2-e · Cited by 485
Drug-induced systemic lupus erythematosus associated with etanercept therapy
Shakoor, N., Michalska, M., Harris, C. A., & Block, J. A. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07714-0 · Cited by 458
Boswell, J. M., Yui, M. A., Burt, D. W., & Kelley, V. E. (1988) · The Journal of Immunology · doi:10.4049/jimmunol.141.9.3050 · Cited by 320
STUDNICKA-BENKE, A., STEINER, G., PETERA, P., & SMOLEN, J. S. (1996) · Rheumatology · doi:10.1093/rheumatology/35.11.1067 · Cited by 280
Self-citationGabay, C., Çakır, N., Moral, F., Roux-Lombard, P., Meyer, O., Dayer, J. M., VISCHER, T. L., Yazici, H., & Guerne, P. (1997) · PubMed · Cited by 230
Kollias, G., Douni, E., Kassiotis, G., & Kontoyiannis, D. (1999) · Annals of the Rheumatic Diseases · doi:10.1136/ard.58.2008.i32 · Cited by 210
Watanabe, H., Garnier, G., Circolo, A., Wetsel, R. A., Ruiz, P., Holers, V. M., Boackle, S. A., Colten, H. R., & Gilkeson, G. S. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.2.786 · Cited by 207
Signaling by the TNF Receptor Superfamily and T Cell Homeostasis
Chan, F. K.-M., Siegel, R. M., & Lenardo, M. J. (2000) · Immunity · doi:10.1016/s1074-7613(00)00041-8 · Cited by 200
Antoni, C., Dechant, C., Hanns‐Martin Lorenz, P. D., Wendler, J., Ogilvie, A., Lueftl, M., Kalden‐Nemeth, D., Kalden, J. R., & Manger, B. (2002) · Arthritis Care & Research · doi:10.1002/art.10671 · Cited by 177
Aderka, D., Wysenbeek, A., Engelmann, H., Cope, A. P., Brennan, F., Molad, Y., Hornik, V., Levo, Y., Maini, R. N., Feldmann, M., et al. (1993) · Arthritis & Rheumatism · doi:10.1002/art.1780360812 · Cited by 174
Chronic therapy with recombinant tumor necrosis factor-α in autoimmune NZB/NZW F1 mice
Gordon, C., Ranges, G. E., Greenspan, J. S., & Wofsy, D. (1989) · Clinical Immunology and Immunopathology · doi:10.1016/0090-1229(89)90157-8 · Cited by 167
Debets, J. M. H., van der Linden, J., Dieteren, I. E. M., et al. (1988) · The Journal of Immunology · doi:10.4049/jimmunol.141.4.1197 · Cited by 159
Bencivelli, W., Vitali, C., Isenberg, D. A., Smolen, J. S., Snaith, M. L., Sciuto, M. E., & Bombardieri, S. (1992) · PubMed · Cited by 154
Self-citationTumor necrosis factor in the serum of patients with systemic lupus erythematosus
Maury, C. P. J., & Teppo, A. M. (1989) · Arthritis & Rheumatism · doi:10.1002/anr.1780320206 · Cited by 149
Nucleosomes and histones are present in glomerular deposits in human lupus nephritis
van Bruggen, M. C. J., Kramers, C., Walgreen, B., Elema, J., Kallenberg, C. G. M., van den Born, J., Smeenk, R. J. T., Assmann, K. J. M., Muller, S., Monestier, M., et al. (1997) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/12.1.57 · Cited by 140
Serum interleukin‐15 is elevated in systemic lupus erythematosus
Aringer, M., Stummvoll, G. H., Steiner, G. E., Köller, M. D., Steiner, C. W., Höfler, E., Hiesberger, H., Smolen, J. S., & Graninger, W. B. (2001) · Lara D. Veeken · doi:10.1093/rheumatology/40.8.876 · Cited by 115
Self-citationIncreased bioactive TNF in human systemic lupus erythematosus: associations with cell death
Aringer, M., Feierl, E., Steiner, G. E., Stummvoll, G. H., Höfler, E., Steiner, C. W., Radda, I., Smolen, J. S., & Graninger, W. B. (2002) · Lupus · doi:10.1191/0961203302lu160oa · Cited by 110
Self-citationBao, L., Haas, M., Boackle, S. A., Kraus, D., Cunningham, P. N., Park, P., Alexander, J. J., Anderson, R. K., Culhane, K. K., Holers, V. M., et al. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.7.3601 · Cited by 107
Aringer, M., & Smolen, J. S. (2003) · Arthritis Research · doi:10.1186/ar770 · Cited by 105
Self-citationHopkinson, N., Jenkinson, C., Muir, K. R., Doherty, M., & Powell, R. J. (2000) · Annals of the Rheumatic Diseases · doi:10.1136/ard.59.2.116 · Cited by 65
Meijer, C., Huysen, V., Smeenk, R. J. T., & Swaak, A. J. G. (1993) · Lupus · doi:10.1177/096120339300200605 · Cited by 60
Smolen, J. S., Butcher, B. T., Fritzler, M. J., Gordon, T., Hardin, J., Kalden, J. R., Lahita, R. G., Maini, R. N., Reeves, W. H., Reichlin, M., et al. (1997) · Arthritis & Rheumatism · doi:10.1002/art.1780400304 · Cited by 57
Self-citationThe role of autoantibodies in the pathogenesis of lupus nephritis.
Madaio, M. P. (1999) · PubMed · Cited by 52
Abnormal Splenic and Thymic IL‐4 and TNF‐α Expression in MRL‐lpr/lpr Mice
Tsai, C., Wu, T., Huang, S., Sun, K., Hsieh, S., HAN, S. ‐., Yu, H.-S., & YU, C. L. (1995) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.1995.tb03548.x · Cited by 45
Targeted Therapies in Rheumatology
Bresnihan, B. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-140-2-200401200-00035 · Cited by 34
New prospects for treatment of lupus nephritis.
Balow, J. E., Boumpas, D. T., & Austin, H. A. (2000) · PubMed · Cited by 19
Shigeyama (2000) · doi:10.1002/1529-0131(200011)43:11
Cited by
Rahman, A., & Isenberg, D. A. (2008) · New England Journal of Medicine · doi:10.1056/nejmra071297 · Cited by 1,632
Tumor necrosis factor antagonist mechanisms of action: A comprehensive review
Tracey, D., Klareskog, L., Sasso, E. H., Salfeld, J. G., & Tak, P. P. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.10.001 · Cited by 1,628
Type I Interferon in Systemic Lupus Erythematosus and Other Autoimmune Diseases
Banchereau, J., & Pascual, V. (2006) · Immunity · doi:10.1016/j.immuni.2006.08.010 · Cited by 963
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010
Furst, D. E., Keystone, E. C., Braun, J., Breedveld, F. C., Burmester, G. R., De Benedetti, F., Dörner, T., Emery, P., Fleischmann, R., Gibofsky, A., et al. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.146852 · Cited by 687
Self-citationAnti-TNF therapy: past, present and future
Monaco, C., Nanchahal, J., Taylor, P., & Feldmann, M. (2015) · International Immunology · doi:10.1093/intimm/dxu102 · Cited by 581
Metadata
- Authors
- Aringer, M., Graninger, W. B., Steiner, G., & Smolen, J. S.
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 2004-10
- Volume
- 50
- Issue
- 10
- Pages
- 3161-3169
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- OpenAlex
- W2008489937
- Cited by
- 342
- References
- 39
- FWCI
- 19.68
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.